Results 71 to 80 of about 13,750 (216)

Castleman disease presenting as lymphadenopathy in a female with systemic lupus erythematosus: A rare case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Castleman disease is an infrequent disease that affects the lymph nodes and related tissues. The condition may manifest with lymphadenopathy, characterized by the enlargement of the lymph nodes, alongside additional symptoms such as ...
Alireza Khabbazi   +4 more
doaj   +1 more source

Unicentric castleman's disease located in the lower extremity: a case report [PDF]

open access: yes, 2011
Background Castleman's disease is a rare form of localized lymph node hyperplasia of uncertain etiology. Although the mediastinum is the most common site of involvement, rare cases occurring in lymph node bearing tissue of other localization have been ...
A Slotwiner   +13 more
core   +5 more sources

Primary mediastinal Castleman's disease

open access: yesRare Tumors, 2010
Castleman's disease is a rare entity with an unknown etiology which was first described by Castleman in 1954. It is a lymphoproliferative disorder histologically classified into three types; hyaline-vascular, plasma cell type and mixed type. It might be localized or multicentric and usually involves the mediastinum.
Hanan Bousbait   +2 more
openaire   +3 more sources

Neurological Peculiarities of POEMS Syndrome: Experience From a Brazilian University Center

open access: yesMuscle &Nerve, Volume 73, Issue 3, Page 421-426, March 2026.
ABSTRACT Aim Polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes (POEMS) syndrome is a rare paraneoplastic syndrome associated with significant neurologic morbidity. Better understanding of the manifestations of this disease is crucial to early diagnosis and improvement of prognosis.
Renan Fabri Rosenstein   +5 more
wiley   +1 more source

Violaceous nodules in an HIV-positive man [PDF]

open access: yes, 2020
Plasmablastic lymphoma (PBL) is a rare and aggressive malignancy associated with immunosuppression and the oncogenic effects of the Epstein-Barr virus (EBV).
Dominguez, Arturo R   +2 more
core  

Idiopathic Multicentric Castleman's Disease Diagnosed by Pulmonary Histopathology: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
Based on the diagnostic criteria, lymph node biopsy is necessary to diagnose idiopathic multicentric Castleman's disease (iMCD). We report a case of iMCD diagnosed using lung and lymph node histopathological findings in a 41‐year‐old woman who presented with inflammatory symptoms and pulmonary lesions.
Yuki Kurihara   +11 more
wiley   +1 more source

HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Patients with acquired immunodeficiency syndrome (AIDS) are at an increased susceptibility to pathogens and associated malignancies which can present with a unique constellation of symptoms.
Robert Dunn MS4   +6 more
doaj   +1 more source

HIV-associated multi-centric Castleman’s disease with multiple organ failure: cuccessful treatment with rituximab [PDF]

open access: yes, 2010
Introduction: Multicentric Castleman's Disease (MCD), a lymphoproliferative disorder associated with Human Herpes Virus-8 (HHV-8) infection, is increasing in incidence amongst HIV patients.
Agarwal, B   +7 more
core  

Surgical treatment of unicentric plasma cell histological type Castleman's disease [PDF]

open access: yes, 2011
Introduction. Castleman’s disease or angiofollicular lymph hyperplasia is a rare disease with two identified clinical forms. Unicentric or localized form is characterized by isolated growth of lymph nodes, most often in mediastinum, and multicentric ...
Cvijanović Vlado   +6 more
core   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

open access: yesClinical and Translational Medicine, Volume 16, Issue 2, February 2026.
This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley   +1 more source

Home - About - Disclaimer - Privacy